2012 - 2014 Metastasis initiating cell of lung cancer brain metastases
Papers (24)：
Koji Fukuda, Shinji Takeuchi, Sachiko Arai, Shigeki Nanjo, Shigeki Sato, Hiroshi Kotani, Kenji Kita, Akihiro Nishiyama, Hiroyuki Sakaguchi, Koshiro Ohtsubo, et al. Targeting WEE1 enhances the antitumor effect of KRAS-mutated non-small cell lung cancer harboring TP53 mutations. Cell reports. Medicine. 2024. 101578-101578
Yuki Katayama, Tadaaki Yamada, Shinsaku Tokuda, Naoko Okura, Naoya Nishioka, Kenji Morimoto, Keiko Tanimura, Yoshie Morimoto, Masahiro Iwasaku, Mano Horinaka, et al. Heterogeneity among tumors with acquired resistance to EGFR tyrosine kinase inhibitors harboring EGFR-T790M mutation in non-small cell lung cancer cells. Cancer medicine. 2022. 11. 4. 944-955
Kenji Kita. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer. The Journal of pathology. 2022. 257. 1. 39-52
Toshikatsu Tsuji, Yusuke Maeda, Kenji Kita, Kazuhiro Murakami, Hideyuki Saya, Hirofumi Takemura, Noriyuki Inaki, Masanobu Oshima, Hiroko Oshima. FOXO3 is a latent tumor suppressor for FOXO3-positive and cytoplasmic-type gastric cancer cells. Oncogene. 2021. 40. 17. 3072-3086
S. Yano, S. Arai, K. Kita, A. Tanimoto, S. Takeuchi. Anti-tumor activity of alectinib in the orthotopic in vivo imaging model with NCOA4-RET fusion positive tumor cells. ANNALS OF ONCOLOGY. 2017. 28
Akihiro Nishiyama, Kenji Kita, Shoko Arai, Shinji Takeuchi, Tadaaki Yamada, Seiji Yano. In vivo Imaging Models for Preclinical Screening of Molecular Targeted Drugs against Brain Metastasis. JOURNAL OF THORACIC ONCOLOGY. 2017. 12. 1. S561-S562
